MTOR and prostate carcinoma: Similarly, in an independent study, we demonstrated that castration-resistant prostate cancer cells also depend on BRPF1 in docetaxel and cabazitaxel resistance, highlighting BRPF1’s role as an ABCB1 regulator controlling mTOR and unfolded protein response (UPR) signaling62.